-Dr. Kathy Johnson, PhD, CMC
A new report recently released in Archives of Neurology indicates that early Alzheimer’s diseases, in which a compound binds to brain plaques, is likely to turn into Alzheimer’s with dementia. The results of this survey bring about the realization that preclinical Alzheimer’s disease is not benign. It will eventually cause synpatic and neurological damage that will cause a cognitive decline and other effects of Alzheimer’s.
Autopsies were done on those with preclinical Alzheimer’s, which showed tangles and deposits of beta-amyloid, which are characteristics of Alzheimer’s disease. The research was conducted by using a compound known as Pittsburgh Compound B, which binds with beta-amyloid. Those individuals in whom the compound bounded to more beta-amyloid plaques would develop Alzheimer’s with dementia, researchers noted.
Great article I’ve just added to my bookmark list.